Privi Speciality Chemicals Limited (BOM: 530117)
1,484.60
-19.15 (-1.27%)
At close: Sep 10, 2024
Privi Speciality Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Revenue | 18,075 | 17,522 | 16,078 | 14,037 | 12,766 | 13,241 | Upgrade
|
Revenue Growth (YoY) | 11.04% | 8.98% | 14.54% | 9.96% | -3.59% | -1.26% | Upgrade
|
Cost of Revenue | 11,720 | 11,612 | 11,281 | 9,466 | 7,658 | 8,175 | Upgrade
|
Gross Profit | 6,355 | 5,910 | 4,797 | 4,571 | 5,107 | 5,066 | Upgrade
|
Selling, General & Admin | 750.3 | 727.36 | 796.88 | 766.85 | 700.3 | 652.34 | Upgrade
|
Other Operating Expenses | 1,955 | 1,930 | 2,135 | 1,866 | 2,331 | 2,243 | Upgrade
|
Operating Expenses | 3,954 | 3,892 | 4,016 | 3,380 | 3,741 | 3,463 | Upgrade
|
Operating Income | 2,401 | 2,018 | 780.79 | 1,192 | 1,366 | 1,604 | Upgrade
|
Interest Expense | -963.98 | -979.39 | -678.13 | -241.13 | -214.1 | -341.09 | Upgrade
|
Interest & Investment Income | 3.22 | 3.22 | 2.82 | 2.99 | 4.81 | 7.71 | Upgrade
|
Currency Exchange Gain (Loss) | 188.28 | 188.28 | 182.08 | 295 | 185.67 | 200.41 | Upgrade
|
Other Non Operating Income (Expenses) | -9.94 | 24.16 | 22.37 | 10 | 7.05 | 54.65 | Upgrade
|
EBT Excluding Unusual Items | 1,619 | 1,254 | 309.94 | 1,259 | 1,349 | 1,526 | Upgrade
|
Gain (Loss) on Sale of Investments | 25.45 | 25.45 | 6.18 | 0.03 | 1.86 | 0.05 | Upgrade
|
Gain (Loss) on Sale of Assets | 19.32 | 19.32 | -5.94 | 0.07 | 0.03 | - | Upgrade
|
Other Unusual Items | - | - | 0.26 | -163.26 | 0.17 | 0.78 | Upgrade
|
Pretax Income | 1,663 | 1,299 | 310.43 | 1,328 | 1,582 | 1,926 | Upgrade
|
Income Tax Expense | 439.71 | 344.8 | 97.65 | 353.74 | 413.22 | 466.04 | Upgrade
|
Earnings From Continuing Operations | 1,224 | 954.3 | 212.78 | 973.8 | 1,169 | 1,460 | Upgrade
|
Minority Interest in Earnings | -7.2 | -5.22 | 9.37 | - | - | - | Upgrade
|
Net Income | 1,217 | 949.07 | 222.15 | 973.8 | 1,169 | 1,460 | Upgrade
|
Net Income to Common | 1,217 | 949.07 | 222.15 | 973.8 | 1,169 | 1,460 | Upgrade
|
Net Income Growth | 2620.11% | 327.23% | -77.19% | -16.70% | -19.95% | 54.95% | Upgrade
|
Shares Outstanding (Basic) | 39 | 39 | 39 | 39 | 39 | 39 | Upgrade
|
Shares Outstanding (Diluted) | 39 | 39 | 39 | 39 | 39 | 39 | Upgrade
|
Shares Change (YoY) | -1.52% | - | 0.00% | - | - | -0.00% | Upgrade
|
EPS (Basic) | 31.38 | 24.30 | 5.69 | 24.93 | 29.93 | 37.38 | Upgrade
|
EPS (Diluted) | 31.38 | 24.30 | 5.69 | 24.93 | 29.93 | 37.38 | Upgrade
|
EPS Growth | 2662.04% | 327.23% | -77.19% | -16.70% | -19.94% | 54.93% | Upgrade
|
Free Cash Flow | - | 2,040 | -909.33 | -3,039 | -934.89 | 357.3 | Upgrade
|
Free Cash Flow Per Share | - | 52.22 | -23.28 | -77.80 | -23.93 | 9.15 | Upgrade
|
Dividend Per Share | - | 2.000 | - | 2.000 | 2.000 | 1.500 | Upgrade
|
Dividend Growth | - | - | - | 0% | 33.33% | -40.00% | Upgrade
|
Gross Margin | 35.16% | 33.73% | 29.84% | 32.57% | 40.01% | 38.26% | Upgrade
|
Operating Margin | 13.28% | 11.52% | 4.86% | 8.49% | 10.70% | 12.11% | Upgrade
|
Profit Margin | 6.73% | 5.42% | 1.38% | 6.94% | 9.16% | 11.03% | Upgrade
|
Free Cash Flow Margin | - | 11.64% | -5.66% | -21.65% | -7.32% | 2.70% | Upgrade
|
EBITDA | 3,596 | 3,175 | 1,787 | 1,903 | 2,044 | 2,143 | Upgrade
|
EBITDA Margin | 19.90% | 18.12% | 11.11% | 13.56% | 16.01% | 16.18% | Upgrade
|
D&A For EBITDA | 1,195 | 1,157 | 1,006 | 711.28 | 678.2 | 538.91 | Upgrade
|
EBIT | 2,401 | 2,018 | 780.79 | 1,192 | 1,366 | 1,604 | Upgrade
|
EBIT Margin | 13.28% | 11.52% | 4.86% | 8.49% | 10.70% | 12.11% | Upgrade
|
Effective Tax Rate | 26.43% | 26.54% | 31.46% | 26.65% | 26.12% | 24.19% | Upgrade
|
Revenue as Reported | 18,304 | 17,785 | 16,292 | 14,361 | 12,965 | 13,505 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.